ATE389411T1 - Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz - Google Patents

Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz

Info

Publication number
ATE389411T1
ATE389411T1 AT02765057T AT02765057T ATE389411T1 AT E389411 T1 ATE389411 T1 AT E389411T1 AT 02765057 T AT02765057 T AT 02765057T AT 02765057 T AT02765057 T AT 02765057T AT E389411 T1 ATE389411 T1 AT E389411T1
Authority
AT
Austria
Prior art keywords
treatment
soft tissue
sub
strontium compound
tissue pain
Prior art date
Application number
AT02765057T
Other languages
English (en)
Inventor
Egil Jellum
Bjorn Jarl Fagerlund
Clas Magne Kjolberg
Jo Klaveness
Original Assignee
Santosolve As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santosolve As filed Critical Santosolve As
Application granted granted Critical
Publication of ATE389411T1 publication Critical patent/ATE389411T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • External Artificial Organs (AREA)
  • Surgical Instruments (AREA)
  • Inorganic Insulating Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02765057T 2001-09-28 2002-09-27 Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz ATE389411T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20014746A NO20014746D0 (no) 2001-09-28 2001-09-28 Smertelindrende middel

Publications (1)

Publication Number Publication Date
ATE389411T1 true ATE389411T1 (de) 2008-04-15

Family

ID=19912876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02765057T ATE389411T1 (de) 2001-09-28 2002-09-27 Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz

Country Status (12)

Country Link
US (4) US7241460B2 (de)
EP (2) EP1741436A1 (de)
JP (1) JP4750358B2 (de)
CN (2) CN1981780A (de)
AT (1) ATE389411T1 (de)
CA (1) CA2499814C (de)
DE (1) DE60225702T2 (de)
DK (1) DK1429792T3 (de)
ES (1) ES2303860T3 (de)
NO (1) NO20014746D0 (de)
PT (1) PT1429792E (de)
WO (1) WO2003028742A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383519B1 (en) 1999-01-26 2002-05-07 Vita Special Purpose Corporation Inorganic shaped bodies and methods for their production and use
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
CA2561082C (en) * 2003-03-27 2014-07-15 Santosolve As Anti-inflammatory treatment based on strontium compounds
EP1622629B1 (de) * 2003-05-07 2013-07-10 Osteologix A/S Strontiumzubereitung mit kontrollierter Freisetzung
EP1745791B1 (de) 2003-05-07 2013-06-26 Osteologix A/S Behandlung von Knorpel/Knochen-Erkrankungen mit wasserlöslichen Strontiumsalzen
ES2394782T3 (es) * 2003-05-07 2013-02-05 Osteologix A/S Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos
EP1523985B1 (de) * 2003-10-17 2010-03-10 Oy Neurofood Ab Nicht-radioaktives Strontiummittel zur Behandlung von Krebs
CA2557324C (en) * 2004-02-26 2012-10-16 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
SI1732575T1 (sl) * 2004-02-26 2011-05-31 Osteologix As Spojine, ki vsebujejo stroncij, za uporabo pri preprečevanju ali zdravljenju nekrotičnih kostnih stanj
EP1744770A2 (de) * 2004-05-06 2007-01-24 Osteologix A/S Schnelle synthesemethoden mit hoher ausbeute zur herstellung von metallorganischen salzen
AU2005254154A1 (en) * 2004-06-17 2005-12-29 Osteologix A/S Improving pain treatment with strontium combinations
US20090035315A1 (en) * 2004-06-17 2009-02-05 Stephan Christgau Method of Improving Treatments in Rheumatic and Arthritic Diseases
LT2801354T (lt) 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
GB2425060A (en) * 2005-03-24 2006-10-18 Santosolve As Strontium compounds in cosmetics
AU2006265491A1 (en) * 2005-07-06 2007-01-11 Osteologix A/S High yield synthesis methods for producing organic salts of strontium
US9421302B2 (en) 2006-05-26 2016-08-23 Baxter International Inc. Injectable fibrin composition for bone augmentation
ES2573327T3 (es) * 2007-04-23 2016-06-07 Baxter International Inc. Composiciones de fibrina que contienen compuestos de estroncio
WO2010079222A1 (en) 2009-01-09 2010-07-15 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
CN102976997A (zh) * 2009-05-27 2013-03-20 天津和美生物技术有限公司 阿伐他汀半锶盐多晶型物、其制备和作为HMG-CoA酶抑制剂的应用
US8615888B2 (en) * 2009-06-30 2013-12-31 Dexter-Russell, Inc. Impaired grip knife
WO2011041468A1 (en) 2009-09-29 2011-04-07 Georgia Tech Research Corporation Electrodes, lithium-ion batteries, and methods of making and using same
WO2011140150A1 (en) * 2010-05-03 2011-11-10 Georgia Tech Research Corporation Alginate-containing compositions for use in battery applications
PE20140936A1 (es) * 2011-05-03 2014-08-06 Aponia Lab Inc Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas
EP2530068A1 (de) 2011-05-31 2012-12-05 Lacer, S.A. Neue Strontiumsalze, deren Synthese und Verwendung bei der Behandlung von Osteoporose
EP2827847B1 (de) * 2012-03-21 2022-09-14 Galleon Labs LLC Topisch anwendbare strontiumhaltige komplexe zur behandlung von schmerzen, juckreiz und entzündungen
US9480704B2 (en) 2012-03-21 2016-11-01 Cosmederm Bioscience, Inc. Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
WO2016141219A1 (en) * 2015-03-05 2016-09-09 Cosmederm Bioscience, Inc. Strontium based compositions and formulations for pain, pruritus, and inflammation
US11235002B2 (en) 2015-08-21 2022-02-01 Galleon Labs Llc Strontium based compositions and formulations for pain, pruritus, and inflammation
US20170049807A1 (en) * 2015-08-21 2017-02-23 Cosmederm Bioscience, Inc. Strontium based compositions and formulations for pain, pruritus, and inflammation
WO2018084959A2 (en) 2016-09-30 2018-05-11 Nelson Deanna J Pharmaceutical quality strontium l-lactate

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865933A (en) * 1972-05-24 1975-02-11 C And A Lab Inc Analgesic composition
US3988434A (en) * 1972-08-07 1976-10-26 Schole Murray L Dental preparation
US4083965A (en) * 1975-01-16 1978-04-11 Bluhm Henry P Method of and composition for relieving itch, pain and swelling resulting from insect stings and bites and skin contact with noxious plants
US4363818A (en) * 1975-06-04 1982-12-14 Gottlieb Sheldon K Method for relief of burning, itching, and pain of cutaneous and mucosal surfaces
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
JPS6022946B2 (ja) * 1976-09-24 1985-06-05 東レ株式会社 生体用透析装置の滅菌法
JPS53148542A (en) * 1977-05-27 1978-12-25 Reiichi Yamaga Pharmaceutical composition densistry
CA1179267A (en) 1982-03-22 1984-12-11 Larry Barron Composition for relieving toothache pain
US4634589A (en) * 1984-05-18 1987-01-06 Wurttembergische Parfumerie-Fabrik Gmbh Dentifrice for hypersensitive teeth
KR870700024A (ko) 1984-07-12 1987-02-28 원본미기재 약, 비타민 또는 왁진의 근육내 주사용 제제
JPH0742219B2 (ja) * 1984-07-26 1995-05-10 ライオン株式会社 口腔用組成物
US4650668A (en) * 1984-12-21 1987-03-17 Larry Barron Composition for relieving toothache pain and other forms of intense pain
US4756909A (en) * 1986-04-28 1988-07-12 Elena Avram Method for relieving pain or producing analgesia with n-butanol
US5330746A (en) * 1988-05-03 1994-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental varnish composition, and method of use
US4866046A (en) 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
JP2638635B2 (ja) * 1989-01-31 1997-08-06 積水化学工業株式会社 経皮吸収製剤
US5234971A (en) * 1989-12-28 1993-08-10 G-C Dental Industrial Corp. Odontotherapeutical materials
US5855870A (en) * 1990-03-22 1999-01-05 Ultradent Products, Inc. Method for treating sensitive teeth
US5851512A (en) * 1990-03-22 1998-12-22 Ultradent Products, Inc. Dental compositions having a sticky matrix material for treating sensitive teeth
US5188818A (en) * 1992-03-30 1993-02-23 Isp Investments Inc. Toothpaste composition containing strontium salt of maleic anhydride-methyl vinyl ether copolymer
US5260289A (en) * 1992-06-12 1993-11-09 Vitacain Pharmaceutical Co., Ltd. Composition for treating pain, method for treating pain and composition for reinforcing pain relief action
JPH061721A (ja) 1992-06-16 1994-01-11 Bitakain Seiyaku Kk 疼痛処置剤、及び疼痛軽減作用増強剤
JPH08502976A (ja) 1992-10-29 1996-04-02 シー−ピー テクノロジー リミテッド パートナーシップ カルシウムおよび硫酸塩を含有した組成物および複合体、その合成法、これを用いた治療法、これを含んでなる化粧用調製物
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
GB9413873D0 (en) 1994-07-09 1994-08-31 Norbrook Lab Ltd Long-acting oxytetracycline composition
US5804203A (en) * 1994-12-21 1998-09-08 Cosmederm Technologies Topical product formulations containing strontium for reducing skin irritation
US6139850A (en) * 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
EP0737471A3 (de) * 1995-04-10 2000-12-06 L'oreal Verwendung von Erdalkalimetallsalze als TNF-alpha Inhibitor in einer topischen Zusammensetzung und die so hergestellte Zusammensetzung
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
US5958436A (en) * 1995-12-21 1999-09-28 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5922765A (en) 1996-01-18 1999-07-13 Fleming & Company, Pharmaceuticals Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength
FR2749759B1 (fr) 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
US5914129A (en) 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
EP0834319A1 (de) 1996-10-07 1998-04-08 Kartar Dr. Lalvani Mineral-und Vitaminzubereitungen zur Behandlung von arthritische Schmerzen
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use
US6468809B1 (en) * 2000-02-04 2002-10-22 The United States Of America As Represented By The Secretary Of The Navy High efficiency magnetic sensor for magnetic particles
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel

Also Published As

Publication number Publication date
US7241460B2 (en) 2007-07-10
US20150265649A1 (en) 2015-09-24
ES2303860T3 (es) 2008-09-01
CA2499814C (en) 2011-07-26
NO20014746D0 (no) 2001-09-28
CN1981780A (zh) 2007-06-20
WO2003028742A1 (en) 2003-04-10
EP1741436A1 (de) 2007-01-10
US20050013877A1 (en) 2005-01-20
DE60225702T2 (de) 2008-11-20
PT1429792E (pt) 2008-07-01
US20070237836A1 (en) 2007-10-11
JP4750358B2 (ja) 2011-08-17
CN1585646A (zh) 2005-02-23
DE60225702D1 (de) 2008-04-30
US20110038953A1 (en) 2011-02-17
CN100415247C (zh) 2008-09-03
EP1429792B1 (de) 2008-03-19
CA2499814A1 (en) 2003-04-10
US9050312B2 (en) 2015-06-09
JP2005507396A (ja) 2005-03-17
DK1429792T3 (da) 2008-07-14
EP1429792A1 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE389411T1 (de) Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
EP1605956A4 (de) Verabreichung von capsaicinoiden
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
DE60101265D1 (de) Behandlung von augenschmerzen
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
DE602006016235D1 (de) Einweg-vorrichtung zur behandlung von infektionen der menschlichen extremitäten
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
WO2004084920A3 (en) Anti-inflammatory treatment based on strontium compounds
DE60213116D1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
DE60141759D1 (de) Methode zur behandlung des zentralnervensystems durch applikation von strukturanaloga von igf
DE60105053D1 (de) Zusammensetzungen zur behandlung von gewebe
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
DK1399186T3 (da) Lægemiddel til behandling af tumorer og disses metastaser under anvendelse af et bindemolekyle mod knogle-sialoprotein
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1429792

Country of ref document: EP